iron deficiency

News

Australia's CSL makes $11.7bn bid for Swiss pharma Vifor

Australian biotech group CSL has agreed a deal to acquire Swiss drugmaker Vifor Pharma in an all-cash deal that expands its speciality medicines business.

News

Vifor forges iron drug partnership with Fresenius in China

Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs.

News

Red blood cells moving in blood vessels with depth of field.

Shield Therapeutics soars on FDA approval of iron deficiency...

Shares in Shield Therapeutics were soaring this morning after the FDA granted a broader than expected label for its iron deficiency drug.

Australia's CSL makes $11.7bn bid for Swiss pharma Vifor

Vifor forges iron drug partnership with Fresenius in China

Shield Therapeutics soars on FDA approval of iron deficiency...

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks